ONX-7: eligible for GI-04 · confidence ≥ 70%

Patients needing attention

Synthetic demo data

Biological stateToxicity risk ≥Discontinuation risk ≥Predicted response ≥Predicted response ≤Days on treatment ≥Days on treatment ≤ClusterPrior interventionEligible forConfidence ≥

Clear

patients · ONX-7: eligible for GI-04 · confidence ≥ 70%

Create intervention

Most common reason

GI intolerance

Most effective previous action

GI-04

Nutritional protocol

Estimated addressable population

eligible for GI-04, confidence ≥ 70%

Predicted persistence gain

+17%

Patient	Day	Baseline	GI	Tolerance	GI score	Discontinuation	Cluster
P-03332	98	S14	Unstable	Stable	77	96%	EC-03
P-03341	142	S14	Unstable	Deteriorating	71	96%	EC-03
P-03345	145	S14	Unstable	Deteriorating	73	96%	EC-03
P-03390	138	S14	Unstable	Deteriorating	70	96%	EC-03
P-03413	150	S14	Unstable	Improving	78	96%	EC-03
P-03430	121	S14	Unstable	Improving	61	92%	EC-03
P-03460	127	S11	Unstable	Deteriorating	63	88%	EC-03
P-03099	148	S17	Unstable	Improving	68	74%	LT
P-03365	93	S14	Improving	Improving	42	74%	EC-03